Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives.
anticancer therapy
cisplatin resistance
doxorubicin resistance
gold (III) complexes
prostate cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
04 Apr 2019
04 Apr 2019
Historique:
received:
12
02
2019
revised:
12
03
2019
accepted:
18
03
2019
entrez:
17
4
2019
pubmed:
17
4
2019
medline:
17
4
2019
Statut:
epublish
Résumé
We synthesized eight new bipyridine and bipyrimidine gold (III) dithiocarbamate-containing complexes (
Identifiants
pubmed: 30987271
pii: cancers11040474
doi: 10.3390/cancers11040474
pmc: PMC6521029
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG 15844
Organisme : King Fahd University of Petroleum and Minerals
ID : IN171005
Références
Oncol Res. 2000;12(9-10):361-70
pubmed: 11697815
Cancer Res. 2006 Nov 1;66(21):10478-86
pubmed: 17079469
Anticancer Drugs. 2007 Mar;18(3):323-32
pubmed: 17264766
Free Radic Biol Med. 2007 Mar 15;42(6):872-81
pubmed: 17320769
Chem Biol. 2007 Oct;14(10):1128-39
pubmed: 17961825
Med Res Rev. 2010 May;30(3):550-80
pubmed: 19634148
Int J Cancer. 2011 Jan 1;128(1):206-15
pubmed: 20209498
Int J Cancer. 2011 Jul 15;129(2):487-96
pubmed: 20853318
Free Radic Biol Med. 2010 Dec 15;49(12):2078-87
pubmed: 20955789
J Med Chem. 2012 Mar 8;55(5):2212-26
pubmed: 22309237
PLoS One. 2014 Jan 02;9(1):e84248
pubmed: 24392119
Cell Death Dis. 2014 May 29;5:e1257
pubmed: 24874729
Nat Rev Mol Cell Biol. 2014 Sep;15(9):562-3
pubmed: 25096048
Future Med Chem. 2014 Jul;6(11):1249-63
pubmed: 25162999
J Inorg Biochem. 2014 Dec;141:79-82
pubmed: 25217719
Molecules. 2014 Sep 29;19(10):15584-610
pubmed: 25268716
Dalton Trans. 2015 Feb 28;44(8):3633-9
pubmed: 25470362
Curr Opin Chem Biol. 2015 Apr;25:172-83
pubmed: 25765750
Eur J Med Chem. 2015 May 5;95:464-72
pubmed: 25841201
Biometals. 2015 Oct;28(5):827-44
pubmed: 26099502
Blood. 2015 Sep 10;126(11):1394-7
pubmed: 26228484
Cancer Chemother Pharmacol. 2016 Jun;77(6):1103-24
pubmed: 26886018
Oncotarget. 2017 Jan 3;8(1):490-505
pubmed: 27888799
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433
pubmed: 28117417
Pharmacol Res. 2018 Jan;127:4-14
pubmed: 28336372
Eur J Med Chem. 2017 Dec 15;142:8-31
pubmed: 28442170
Trends Pharmacol Sci. 2017 Sep;38(9):794-808
pubmed: 28648527
Eur J Med Chem. 2017 Sep 29;138:115-127
pubmed: 28651154
Met Ions Life Sci. 2018 Feb 5;18:
pubmed: 29394026
Curr Med Chem. 2018 Feb 12;25(4):434-436
pubmed: 29494325
Chemistry. 2018 Aug 14;24(46):11840-11851
pubmed: 29575433
Free Radic Biol Med. 2018 Nov 1;127:62-79
pubmed: 29596885
Inorg Chem. 2018 Sep 4;57(17):10832-10845
pubmed: 30117739
F1000Res. 2018 Sep 21;7:
pubmed: 30345007
Adv Enzyme Regul. 1984;22:27-55
pubmed: 6382953
Clin Cancer Res. 1996 Feb;2(2):427-32
pubmed: 9816187